The DOI matches its Crossref record; 137 of the 138 references it cites were found in a registry or an index.
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?
Open accessAbstract
Growing evidence highlights the relevance of microbiota-gut-brain axis in the maintenance of brain homeostasis as well as in the pathophysiology of major neurological and psychiatric disorders, including Parkinson's disease (PD), Alzheimer's disease (AD), multiple sclerosis (MS), autism spectrum disorder (ASD) and major depressive disorder (MDD). In particular, changes in gut microbiota can promote enteric and peripheral neurogenic/inflammatory responses, which, in turn, could contribute to neuroinflammation and neurodegeneration in the central nervous system (CNS). Of note, the nucleotide-binding oligomerization domain leucine rich repeat and pyrin domain-containing protein 3 (NLRP3) inflammasome acts as a key player in both coordinating the host physiology and shaping the peripheral and central immune/inflammatory responses in CNS diseases. In this context, there is pioneering evidence supporting the existence of a microbiota-gut-inflammasome-brain axis, in which enteric bacteria modulate, via NLRP3 signaling, inflammatory pathways that, in turn, contribute to influence brain homeostasis. The present review provides an overview of current knowledge on the role of microbiota-gut-inflammasome-brain axis in the major CNS diseases, including PD, AD, MS, ASD and MDD. In particular, though no direct and causal correlation among altered gut microbiota, NLRP3 activation and brain pathology has been demonstrated and in-depth studies are needed in this setting, our purpose was to pave the way to a novel and pioneering perspective on the pathophysiology of CNS disorders. Our intent was also to highlight and discuss whether alterations of microbiota-gut-inflammasome-brain axis support a holistic view of the pathophysiology of CNS diseases, even though each disorder displays a different clinical picture.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The NLRP3 inflammasome has been found to play a critical role in microbiota-mediated intestinal/peripheral inflammation and neuroinflammation in CNS diseases.102”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [102]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016) · Cell · doi:10.1016/j.cell.2016.05.041 · Cited by 7,070
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752
The gut microbiota--masters of host development and physiology
Sommer, F., & Bäckhed, F. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2974 · Cited by 3,681
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Host microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569
Gut microbiota, metabolites and host immunity
Rooks, M. G., & Garrett, W. S. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.42 · Cited by 3,409
Bauernfeind, F. G., Horvath, G. L., Stutz, A., Alnemri, E. S., MacDonald, K. L., Speert, D. P., Fernandes‐Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 3,087
Research works printed but not linked: 1
- Gordon, 2018, Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice, Sci. Transl. Med., 10
Cited by
Sorted by citations
Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review
Zhao, M., Chu, J., Feng, S., Guo, C., Xue, B., He, K., & Li, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114985 · Cited by 510
Kanmani, S., & Koo, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207551 · Cited by 392
Sun, Y., Koyama, Y., & Shimada, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.903455 · Cited by 304
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
Immunoregulatory role of the gut microbiota in inflammatory depression
Liu, P., Liu, Z., Wang, J., Wang, J., Gao, M., Zhang, Y., Yang, C., Zhang, A., Li, G., Li, X., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47273-w · Cited by 268
The intestinal barrier in disorders of the central nervous system
Pellegrini, C., Fornai, M., D'Antongiovanni, V., Antonioli, L., Bernardini, N., & Derkinderen, P. (2023) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(22)00241-2 · Cited by 239
Self-citationSasso, J. M., Ammar, R. M., Tenchov, R., Lemmel, S. A., Kelber, O., Grieswelle, M., & Zhou, Q. A. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00127 · Cited by 229
Chidambaram, S. B., Essa, M. M., Rathipriya, A. G., Bishir, M., Ray, B., Mahalakshmi, A. M., Tousif, A. H., Sakharkar, M. K., Kashyap, R. S., Friedland, R. P., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107988 · Cited by 204
Neurodegenerative Disease and the NLRP3 Inflammasome
Holbrook, J. A., Jarosz-Griffiths, H., Caseley, E. A., Reyna, S. J. L., Poulter, J. A., Williams‐Gray, C. H., Peckham, D. G., & McDermott, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.643254 · Cited by 201
Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Zhang, X., Tang, B., & Guo, J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00392-8 · Cited by 212
The NLRP3 inflammasome in depression: Potential mechanisms and therapies
Xia, C., Guo, Y., Lian, W., Yan, Y., Ma, B.-Z., Cheng, Y., Xu, J., He, J., & Zhang, W. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106625 · Cited by 188
The NLRP3 inflammasome triggers sterile neuroinflammation and Alzheimer’s disease
Milner, M. T., Maddugoda, M. P., Götz, J., Burgener, S. S., & Schroder, K. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.10.011 · Cited by 162
Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease
Wu, S., Liu, X., Jiang, R., Yan, X., & Ling, Z. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.650047 · Cited by 150
Neuroinflammation: The central enabler of postoperative cognitive dysfunction
Liu, Y., Yang, W., Xue, J., Chen, J., Liu, S., Zhang, S., Zhang, X., Gu, X., Dong, Y., & Qiu, P. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115582 · Cited by 139
Wu, S., Bekhit, A. E. A., Wu, Q., Chen, M., Liao, X., Wang, J., & Ding, Y. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.12.019 · Cited by 129
Yao, H., Zhang, D., Yu, H., Yuan, H., Shen, H., Lan, X., Liu, H., Chen, X., Meng, F., Wu, X., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01841-y · Cited by 125
He, X., Li, L., Xian, W., Li, M., Zhang, L., Xu, J., Pei, Z., Zheng, H., & Hu, X. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02199-8 · Cited by 116
Alpha Synuclein: Neurodegeneration and Inflammation
Forloni, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065914 · Cited by 116
The Role of Microbiome in Brain Development and Neurodegenerative Diseases
Nandwana, V., Nandwana, N. K., Das, Y., Saito, M., Panda, T., Das, S., Almaguel, F. A., Hosmane, N. S., & Das, B. C. (2022) · Molecules · doi:10.3390/molecules27113402 · Cited by 117
Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer’s Disease
Shukla, P. K., Delotterie, D. F., Xiao, J., Pierre, J. F., Rao, R., McDonald, M. P., & Khan, M. M. (2021) · Cells · doi:10.3390/cells10040779 · Cited by 105
Rao, J., Xie, R., Li, L., Jiang, J. H., Du, L., Zeng, X., Li, G., Wang, C., & Qiao, Y. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15192 · Cited by 102
Role of NLRP3 Inflammasome in Rheumatoid Arthritis
Yin, H., Liu, N., Sigdel, K. R., & Duan, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.931690 · Cited by 103
Pellegrini, C., D’Antongiovanni, V., Miraglia, F., Rota, L., Benvenuti, L., Salvo, C. D., Testa, G., Capsoni, S., Carta, G., Antonioli, L., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-021-00263-x · Cited by 96
Self-citationReview of microbiota gut brain axis and innate immunity in inflammatory and infective diseases
Yuan, C., He, Y., Xie, K., Feng, L., Gao, S., & Cai, L. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1282431 · Cited by 87
Cui, Y., Yu, H., Bu, Z., Wen, L., Yan, L.-L., & Feng, J. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.894298 · Cited by 80
Review: The Role of Intestinal Dysbiosis in Parkinson’s Disease
Huang, Y., Liao, J., Liu, X., Zhong, Y., Cai, X., & Long, L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.615075 · Cited by 79
Glymphatic System Pathology and Neuroinflammation as Two Risk Factors of Neurodegeneration
Szlufik, S., Kopeć, K., Szleszkowski, S., & Koziorowski, D. (2024) · Cells · doi:10.3390/cells13030286 · Cited by 84
Intestinal Inflammation and Parkinson’s Disease
Li, Y., Chen, Y., Jiang, L., Zhang, J., Tong, X., Chen, D., & Le, W. (2021) · Aging and Disease · doi:10.14336/ad.2021.0418 · Cited by 75
Wu, J., Li, J., Chhetri, G., Muhammad, U., Chen, Y., Li, X., Chen, J., & Wang, Z. (2021) · General Psychiatry · doi:10.1136/gpsych-2021-100529 · Cited by 70
Yang, L., Cui, Y., Liang, H., Li, Z., Wang, N., Wang, Y., & Zheng, G. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c06283 · Cited by 71
Dong, Z., Shen, X., Hao, Y., Li, J., Li, H., Xu, H., Li, Y., & Kuang, W. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.651536 · Cited by 72
Xiao, L., Zheng, H., Li, J., Zeng, M., He, D., Liang, J., Sun, K., Luo, Y., Li, F., Ping, B., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112797 · Cited by 65
Interactions between gut microbes and NLRP3 inflammasome in the gut-brain axis
Ding, Y., Wang, Z., Chen, Y., Guo, Q., & Dong, Y. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.03.017 · Cited by 69
Zhou, Z., Wang, Y., Sun, S., Zhang, K., Wang, L., Zhao, H., & Zhang, Y. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116716 · Cited by 67
Luo, Y., Yang, L.-L., & Yao, X. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00720-0 · Cited by 75
Alteration of Gut Microbiota: New Strategy for Treating Autism Spectrum Disorder
Liu, J., Gao, Z., Chuanqi, L., Liu, T., Gao, J., Cai, Y., & Fan, X. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.792490 · Cited by 71
Fakhri, S., Yarmohammadi, A., Yarmohammadi, M., Farzaei, M. H., & Echeverría, J. (2021) · Marine Drugs · doi:10.3390/md19030165 · Cited by 52
Microglia and gut microbiota: A double-edged sword in Alzheimer's disease
Bano, N., Khan, S., Ahamad, S., Kanshana, J. S., Dar, N. J., Khan, S. J., Nazir, A., & Bhat, S. A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102515 · Cited by 50
Szabó, D., Tod, P., Gölöncsér, F., Román, V., Lendvai, B., Otrokocsi, L., & Sperlágh, B. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.01.015 · Cited by 46
Wang, X., Shen, C., Wang, X., Tang, J., Wu, Z., Huang, Y., Shao, W., Geng, K., Xie, H., & Pu, Z. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00815-8 · Cited by 45
The gut-lung axis in influenza A: the role of gut microbiota in immune balance
Ou, G., Xu, H., Wu, J., Wang, S., Chen, Y., Deng, L., & Chen, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1147724 · Cited by 49
Ma, T., Gan, G., Cheng, J. G., Shen, Z., Zhang, G., Liu, S., & Hu, J. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202502588 · Cited by 46
Truyens, M., Lernout, H., Vos, M. D., Laukens, D., & Lobatón, T. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1424926 · Cited by 42
Microbiome Dysbiosis: A Pathological Mechanism at the Intersection of Obesity and Glaucoma
Pezzino, S., Sofia, M., Greco, L. P., Litrico, G., Filippello, G., Sarvà, I., Greca, G. L., & Latteri, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021166 · Cited by 39
Dual-directional regulation of spinal cord injury and the gut microbiota
Cui, Y., Liu, J., Xiao, L., Liu, S., Chen, H., Wei, Z., Li, H., Yang, Y., Zheng, C., & Li, Z. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.380881 · Cited by 38
Depression and anxiety in multiple sclerosis. Review of a fatal combination
Jellinger, K. A. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02792-0 · Cited by 48
Woźny-Rasała, I., & Ogłodek, E. A. (2025) · Biomolecules · doi:10.3390/biom15091344 · Cited by 47
Trifiletti, R. R., Lachman, H. M., Manusama, O. R., Zheng, D., Spalice, A., Chiurazzi, P., Schornagel, A., Serban, A. M., van Wijck, R., Cunningham, J. L., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-15279-3 · Cited by 37
Li, Q., Meng, L., Chen, L., Shi, X., Tu, L., Zhou, Q. G., Yu, J.-L., Liao, X., Zeng, Y., & Yuan, Q. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1185375 · Cited by 38
Salvo, C. D., D’Antongiovanni, V., Benvenuti, L., d’Amati, A., Ippolito, C., Segnani, C., Pierucci, C., Bellini, G., Annese, T., Virgintino, D., et al. (2024) · Food & Function · doi:10.1039/d4fo02075h · Cited by 37
Self-citationSeverini, C., Barbato, C., Certo, M. G. D., Gabanella, F., Petrella, C., Stadio, A. D., VINCENTIIS, M. D., Polimeni, A., Ralli, M., & Greco, A. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200621204546 · Cited by 34
The crosstalk between NLRP3 inflammasome and gut microbiome in atherosclerosis
Zhang, X., Yu, Z., Chen, J., Li, X., Wang, Z.-P., Wu, M., & Liu, L. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106289 · Cited by 36
Immune response in retinal degenerative diseases – Time to rethink?
Xu, H., & Chen, M. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102350 · Cited by 33
A review of studies on gut microbiota and levodopa metabolism
Zhong, Z., Ye, M., & Yan, F. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1046910 · Cited by 31
Chen, L., Qing, W., Yi, Z., Lin, G., Peng, Q., & Zhou, F. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.701760 · Cited by 31
Targeting the inflammasome in Parkinson’s disease
Su, Q., Ng, W. L., Goh, S. Y., Gulam, M. Y., Wang, L., Tan, E., Ahn, M., & Chao, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.957705 · Cited by 31
Wang, Y., Liu, Y., Zhang, M., Zhou, H., Gao, Y.-H., Cheng, W., Ye, Z., Yuan, Z.-Y., Xu, G., Li, C., et al. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00348 · Cited by 30
Fan, H., Sheng, S., Li, D., Li, J., Wang, G., & Zhang, F. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10455 · Cited by 31
Yang, H., Shao, Y., Hu, Y., Jin, Q., Wang, P., Tian, L., Ni, Y., Li, S., Al‐Nusaif, M., Liu, C., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70003 · Cited by 33
The gut microbiome, systemic inflammation, and autoimmunity in Parkinson's disease
Fonseca, M. D. C., Zanetti, L., Fanourakis, S., Sulzer, D., & Mazmanian, S. K. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00382-5 · Cited by 29
Liu, H., Liu, L. L., Chen, J., Chen, Y. W., Yue, C., Liu, Q. S., & Cheng, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3322535 · Cited by 29
Gut microbiota: a novel target for exercise-mediated regulation of NLRP3 inflammasome activation
Chen, J., Jia, S., Xue, X., Guo, C., & Dong, K. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1476908 · Cited by 31
Probing gut‐brain links in Alzheimer's disease with rifaximin
Suhocki, P. V., Ronald, J., Diehl, A. M., Murdoch, D. M., & Doraiswamy, P. M. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12225 · Cited by 27
Diet-microbiome-gut-brain nexus in acute and chronic brain injury
Krakovski, M., Arora, N., Jain, S., Glover, J., Dombrowski, K. E., Hernandez, B., Yadav, H., & Sarma, A. K. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1002266 · Cited by 27
Hou, L., Liu, Y., Zhu, C., Miao, J., Zhou, W., Tang, Y., Meng, H., & Liu, S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1107781 · Cited by 28
Reisi‐Vanani, V., Lorigooini, Z., Bijad, E., & Amini-Khoei, H. (2023) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10310 · Cited by 25
Han, S., Bian, R., Chen, Y., Liang, J., Zhao, P., Gu, Y., & Zhang, D. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04229-x · Cited by 27
Zhao, N., 东南大学医学院神经内科, 江. 南. 2., Xiu, C., Chen, Q.-G., Liu, X.-T., Geng, F., Zhu, M., Yan, F., Zhang, Z., Ren, Q., et al. (2024) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2024.085 · Cited by 27
Araújo, L. P., Godoy, A. C. F., Frota, F. F., Lamas, C. B., Quesada, K. R., Detregiachi, C. R. P., Araújo, A. C., Miglino, M. A., Guiguer, É. L., Haber, R. S. D. A., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412147 · Cited by 34
Pharmacological Strategies to Improve Dendritic Spines in Alzheimer’s Disease
Ettcheto, M., Busquets, O., Cano, A. C., Sánchez‐López, E., Manzine, P. R., Espinosa-Jiménez, T., Verdaguer, E., Sureda, F. X., Olloquequi, J., Castro-Torres, R. D., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-201106 · Cited by 25
Inflammasome-Regulated Pyroptotic Cell Death in Disruption of the Gut-Brain Axis After Stroke
Kerr, N. A., Sanchez, J., O’Connor, G., Watson, B. D., Daunert, S., Bramlett, H. M., & Dietrich, W. D. (2022) · Translational Stroke Research · doi:10.1007/s12975-022-01005-8 · Cited by 24
The role of the gut microbiome and its metabolites in cerebrovascular diseases
Xu, H., Xu, Z., Long, S., Li, Z., Jiang, J., Zhou, Q., Huang, X., Wu, X., Wei, W., & Li, X. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1097148 · Cited by 26
The role of pyroptosis in metabolism and metabolic disease
Zheng, Z., Yang, S., Dai, W., Xue, P., Sun, Y., Wang, J., Zhang, X., Jiang, L., & Kong, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116863 · Cited by 28
Lee, J. E., Walton, D. M., O’Connor, C. P., Wammes, M., Burton, J. P., & Osuch, E. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126643 · Cited by 27
Zhong, H., Liu, T., Shang, Y., Huang, C., & Pan, S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117042 · Cited by 24
Vitetta, L., Bambling, M., & Strodl, E. S. (2023) · Microorganisms · doi:10.3390/microorganisms11051334 · Cited by 24
Cheng, J., Williams, J. P., Zhou, L., Wang, P., Sun, L.-N., Li, R., & An, J. (2024) · Medical Gas Research · doi:10.4103/mgr.medgasres-d-23-00036 · Cited by 26
Lin, D. M., Howard, A., Raihane, A. S., Napoli, M. D., Cáceres, E. L., Ortiz, M., Davis, J., Abdelrahman, A. N., & Divani, A. A. (2025) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-025-01410-0 · Cited by 24
The FXR mediated anti-depression effect of CDCA underpinned its therapeutic potentiation for MDD
Li, H., Zhu, X., Xu, J., Li, L., Kan, W., Bao, H., Xu, J., Wang, W., Yang, Y., Chen, P., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109626 · Cited by 23
NLRP3 inflammatory pathway. Can we unlock depression?
Jahromi, G. G., Razi, S., & Rezaei, N. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148644 · Cited by 24
Zhang, P., Liu, Y., Jin, X., Hu, Z., Yang, J., Lu, H. X., Hang, T., & Song, M. O. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241302498 · Cited by 20
Dai, H., Jiang, Y., Liu, S., Li, D., & Zhang, X. (2024) · Food Research International · doi:10.1016/j.foodres.2024.114404 · Cited by 19
Shi, J., Wang, B., Jiang, T., Gao, L., Zhang, Y., & Xu, J. L. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200359 · Cited by 19
Gamal, N. K., El‐Naga, R. N., Ayoub, I. M., & George, M. Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114216 · Cited by 18
Tao, W., Zhang, Y., Wang, B., Nie, S., Li, F., Xiao, J., & Wu, Y. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.03.023 · Cited by 21
Jimenez‐Duran, G., & Triantafilou, M. (2021) · Immunology · doi:10.1111/imm.13326 · Cited by 17
The Metallome as a Link Between the “Omes” in Autism Spectrum Disorders
Stanton, J. E., Malijauskaite, S., McGourty, K., & Grabrucker, A. M. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.695873 · Cited by 16
Maciak, K., Dziedzic, A., & Saluk, J. (2022) · The FASEB Journal · doi:10.1096/fj.202201348r · Cited by 18
Effect of the gut microbiome in glaucoma risk from the causal perspective
Wu, Y., Shi, R., Chen, H., Zhang, Z., Bao, S., Qu, J., & Zhou, M. (2024) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2023-001547 · Cited by 16
Lu, Y., Xu, K., Lin, D., Wang, S., Fu, R., Deng, X., Croppi, G., & Zhang, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.964429 · Cited by 18
The Impact of microRNAs on Mitochondrial Function and Immunity: Relevance to Parkinson’s Disease
Guedes, B. F. S., Cardoso, S. M., & Esteves, A. R. (2023) · Biomedicines · doi:10.3390/biomedicines11051349 · Cited by 16
Torices, S., Daire, L., Simon, S., Mendoza, L., Daniels, D., Joseph, J.-A., Fattakhov, N. S., Naranjo, O., Téglás, T., & Toborek, M. J. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.05.009 · Cited by 15
Microbiome Alterations and Alzheimer’s Disease: Modeling Strategies with Transgenic Mice
López-Villodres, J. A., Escamilla, A., Mercado-Sáenz, S., Alba-Tercedor, C., Rodríguez‐Pérez, L., Arranz‐Salas, I., Sanchez-Varo, R. M., & Bermúdez, D. (2023) · Biomedicines · doi:10.3390/biomedicines11071846 · Cited by 16
Narrative Review: Pathogenesis of the Inflammatory Response and Intestinal Flora in Depression
Zeng, J.-W., Zhao, J.-L., Han, Z.-J., Duan, Y., & Li, L. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s430444 · Cited by 16
The microbiota-inflammasome-brain axis as a pathogenic mediator of neurodegenerative disorders
Sarkar, S. K., Gubert, C., & Hannan, A. J. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106276 · Cited by 15
Zhao, H., Tao, L., Tang, C. W., Cai, W., & Shen, W. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07176-w · Cited by 23
Yu, W., Zhu, Z., & Tang, F. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04228-y · Cited by 16
Lv, H., Wang, S., Tian, M., Wang, L., Gao, J., Zhao, Q., Li, Z., Jia, X., & Yu, Y. (2022) · Mediators of Inflammation · doi:10.1155/2022/2124230 · Cited by 14
Inflammasome Signaling Regulates the Microbial–Neuroimmune Axis and Visceral Pain in Mice
Aguilera, M., Rossini, V., Hickey, A., Simnica, D., Grady, F., Felice, V. D., Moloney, A., Pawley, L. C., Fanning, A., McCarthy, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158336 · Cited by 13
Cai, W., Wei, X.-F., Zhang, J.-R., Tao, L., Li, D., Zhang, K., & Shen, W.-D. (2024) · Neuroreport · doi:10.1097/wnr.0000000000002076 · Cited by 17
Metadata
- Authors
- Pellegrini, C., Antonioli, L., Calderone, V., Colucci, R., Fornai, M., & Blandizzi, C.
- Affiliations
- University of Pisa (IT)
- University of Padua (IT)
- Corresponding author
- Pellegrini, Carolina
- ORCID
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2020-08
- Volume
- 191
- Pages
- 101806
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W3030165573
- Semantic Scholar
- ee46b61c3026c9ee4aa5dbf489c1581b97fa592a
- Cited by
- 174
- References
- 138
- Citations by year
- 2026: 23 · 2025: 31 · 2024: 33 · 2023: 27 · 2022: 34 · 2021: 20 · 2020: 6
- FWCI
- 7.06
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- Locations
- Progress in Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- microbiota-gut-brain axis, NLRP3 inflammasome, gut microbiota, neuroinflammation, neurodegeneration, Parkinson's disease, Alzheimer's disease, multiple sclerosis, autism spectrum disorder, major depressive disorder, neurogenesis, brain homeostasis, central nervous system disorders
- MeSH terms
- Gastrointestinal Microbiome, NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Mental Disorders, Brain Diseases, Humans, Inflammation, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review